Abstract:BackgroundThe production of therapeutically active single chain variable fragment (scFv) antibody is still challenging in E. coli due to the aggregation propensity of recombinant protein into inclusion bodies (IBs). However, recent advancement of biotechnology has shown substantial recovery of bioactive protein from such insoluble IBs by solubilization and refolding processes. In addition, gene fusion technology has also widely been used to improve the soluble protein production using E. coli. This study demonstrates that mild-solubilization and in vitro refolding strategies, both are capable to recover soluble scFv protein from bacterial IBs, although the degree of success is greatly influenced by different fusion tags with the target protein.ResultsIt was observed that the most commonly used fusion tag, i.e., maltose binding protein (MBP) was not only influenced the cytoplasmic expression in E. coli but also greatly improved the in vitro refolding yield of scFv protein. On the other hand, mild solubilization process potentially could recover soluble and functional scFv protein from non-classical IBs without assistance of any fusion tag and in vitro refolding step. The recovery yield achieved by mild solubilization process was also found higher than denaturation–refolding method except while scFv was refolded in fusion with MBP tag. Concomitantly, it was also observed that the soluble protein achieved by mild solubilizationprocess was better structured and functionally more active than the one achieved by in vitro refolding method in the absence of MBP tag or refolding enhancer.ConclusionsMaltose binding protein tagged scFv has shown better refolding and solubility yields as compare to mild solubilization process. However, in terms of cost, time and tag free nature, mild solubilization method for scFv recovery from bacterial IBs is considerable for therapeutic application and further structural studies.

Screening for scFv-fragments that are stable and active in the cytosol

Systematic screening of soluble expression of antibody fragments in the cytoplasm of E. coli

Automated high-throughput purification of antibody fragments to facilitate evaluation in functional and kinetic based assays.

Cell-free eukaryotic systems for the production, engineering, and modification of scFv antibody fragments

Characterization Of Anti-Citrinin Specific Scfvs Selected From Non-Immunized Mouse Splenocytes By Eukaryotic Ribosome Display

Covalent and Oriented Immobilization of Scfv Antibody Fragments Via an Engineered Glycan Moiety

The use of intracellular single-chain antibody fragments to inhibit specifically the expression of cell surface molecules

Improving Expression of scFv Fragments by Co-expression of Periplasmic Chaperones

Evaluation of scFv protein recovery from E. coli by in vitro refolding and mild solubilization process

Separation of E. coli expressing functional cell-wall bound antibody fragments by FACS

A human scFv antibody generation pipeline for proteome research

A generic strategy for subcloning antibody variable regions from the scFv phage display vector pCANTAB 5 E into pASK85 permits the economical production of F(ab) fragments and leads to improved recombinant immunoglobulin stability

In Vivo Applications of Single Chain Fv (Variable Domain) (scFv) Fragments

Shelf-Life Extension of Fc-Fused Single Chain Fragment Variable Antibodies by Lyophilization

A novel and efficient route for the isolation of antibodies that recognise T cell receptor V alpha(s)

Engineering Production of Functional Scfv Antibody in E. Coli by Co-Expressing the Molecule Chaperone Skp

Screening of scFvs against cTnI from Phage Display Antibody Library and Their Expression in E.coli Rosetta

Different Equilibrium Stability Behavior of ScFv Fragments: Identification, Classification, and Improvement by Protein Engineering

Screening of a ScFv Antibody With High Affinity for Application in Human IFN-γ Immunoassay

Improved Soluble ScFv ELISA Screening Approach for Antibody Discovery Using Phage Display Technology

Distinguishing Between Monomeric scFv and Diabody in Solution Using Light and Small Angle X-ray Scattering